Cyclohexyl fentanyl-d5 (hydrochloride) (exempt preparation) |
| Catalog No.GC91606 |
Cyclohexyl fentanyl-d5 (hydrochloride) (exempt preparation) is intended for use as an internal standard for the quantification of cyclohexyl fentanyl by GC- or LC-MS.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2747915-25-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cyclohexyl fentanyl-d5 (hydrochloride) (exempt preparation) is intended for use as an internal standard for the quantification of cyclohexyl fentanyl by GC- or LC-MS. Cyclohexyl fentanyl is categorized as an opioid.[1],[2] Cyclohexyl fentanyl-d5 is regulated as a Schedule I compound in the United States. Cyclohexyl fentanyl-d5 (hydrochloride) (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
References:
[1].Åstrand, A., Vikingsson, S., Jakobsen, I., et al.Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructureDrug Test Anal.13(1)169-174(2020).
[2].Eshleman, A.J., Nagarajan, S., Wolfrum, K.M., et al.Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptorsBiochem. Pharmacol.182114293(2020).
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *